Abstract
Older adults suffering from Parkinson’s disease (PD) frequently present with an additional form of severe neurodegenerative and/or vascular pathology. Findings of differential clinical manifestations of cognitive impairment, depending on presence and nature of such coexisting brain pathology, raise the question for neuropsychological procedures that are capable not only of distinguishing between non-demented PD patients and patients with Parkinson-associated dementia (PDD), but also of detecting other types of cognitive decline, most likely Alzheimer’s disease (AD) or vascular dementia (VD), superimposing PD. The aim of this article is to review the literature on neuropsychological processes at risk in developing PDD, to introduce comorbid causes of cognitive decline in the presence of PD, to discuss the scope of the “cortical versus subcortical dementia”-concept in view of its capability of differentiating dementias, and to scrutinize existing diagnostic criteria concerning the toleration of comorbidity. Additionally, we derive an evidence-based neuropsychological diagnostic procedure for assessing PDD under special consideration of these comorbid aspects.
Similar content being viewed by others
References
Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson’s disease with and without dementia. Int J Geriatr Psychiatry 16:528–536
Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL (2007) Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 78:36–42
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (IV-TR), 4th edn. American Psychiatric Association, Washington, DC
Antal A, Bandini F, Keri S, Bodis-Wollner I (1998) Visuo-cognitive dysfunctions in Parkinson’s disease. Clin Neurosci 5:147–152
Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test (RWT). Hogrefe, Göttingen
Baddeley AD (2001) Is working memory still working? Am Psychol 56:851–864
Baddeley AD, Emslie H, Nimmo-Smith I (1994) The Doors and People Test. Thames Valley Test Company, Bury St. Edmunds
Ballard CG, Aarsland D, McKeith I, O’Brien J, Gray A, Cormack F, Burn D, Cassidy T, Starfeldt R, Larsen JP, Brown R, Tovee M (2002) Fluctuations in attention: PD dementia vs. DLB with parkinsonism. Neurology 59:1714–1720
Benton AL, Hamsher SK, Sivan AB (1983) Multilingual aphasia examination, 2nd edn. AJA Associates, Iowa City
Boeve BF (2007) Parkinson-related dementias. Neurol Clin 25:761–781
Bondi MW, Kaszniak AW, Bayles KA, Vance KT (1993) Contributions of frontal system dysfunction to memory and perceptual abilities in Parkinson’s disease. Neuropsychology 7:89–102
Borek LL, Kohn R, Friedman JH (2007) Phenomenology of dreams in Parkinson’s disease. Mov Disord 22:198–202
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
Braak H, Del Tredici K, Rub U, deVos R, Jansen-Steur E, Braak E (2003) Stageing of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Breen EK (1993) Recall and recognition memory in Parkinson’s disease. Cortex 29:91–102
Bronnick K, Ehrt U, Emre M, De Deyn PP, Wesnes K, Tekin S, Aarsland D (2006) Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease. J Neurol Neurosurg Psychiatry 77:1136–1142
Bronnick K, Emre M, Lane R, Tekin S, Aarsland D (2007) Profile of cognitive impairment in dementia associated with Parkinson’s disease compared with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 78:1064–1068
Brown RG, Marsden CD (1990) Cognitive function in Parkinson’s disease. Trends Neurosci 13:21–29
Bublak P, Muller U, Gron G, Reuter M, von Cramon DY (2002) Manipulation of working memory information is impaired in Parkinson’s disease and related to working memory capacity. Neuropsychology 16:577–590
Camicioli R, Fisher N (2004) Parkinson’s disease with dementia and dementia with Lewy bodies. Can J Neurol Sci 31:7–21
Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA (2003) Parkinson’s disease is associated with hippocampal atrophy. Mov Disord 18:784–790
Capgras J, Reboul-Lachaux J (1923) Illusions des sosies dans un delire systematise chronique. Bull Soc Clin Med Ment 2:6–16
Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, Chang F-L, Skinner K, Tasaki C, Jagust WJ (2000) Clinical criteria for the diagnosis of vascular dementia. A multicenter study of comparability and interrater reliability. Arch Neurol 57:191–196
Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson’s disease and its relationship to motor disability. Brain 114:2095–2122
Cormack F, Aarsland D, Ballard C, Tovée MJ (2004) Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer’s disease, Parkinson’s disease and Parkinson’s disease with dementia. Int J Geriatr Psychiatry 19:371–377
Corsi PM (1972) Human memory and the medial temporal region of the brain. Dissertation abstracts international, 34, 819B
Cummings JL (1992) Depression and Parkinson’s disease: a review. Am J Psychiatry 149:443–454
Cummings JL, Benson F (1984) Subcortical dementia. Arch Neurol 41:874–879
De Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology 54:21–23
Delis DC, Kramer JH, Kaplan E, Ober BA (1987) California verbal learning test. The Psychological Corporation, New York
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007a) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 22:2314–2324
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brian J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007b) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746
Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, de Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R (2004) Rivastigmine for dementia associated with Parkinson’s disease. N Engl J Med 351:2509–2518
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707
Ertan FS, Ertan T, Kiziltan G, Uygucgil H (2005) Reliability and validity of the Geriatric Depression Scale in depression in Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:1445–1447
Evarts EV, Taravainen H, Calne DB (1981) Reaction times in Parkinson’s disease. Brain 104:167–186
Fama R, Sullivan EV, Shear PK, Stein M, Yesavage JA, Tinklenberg JR, Pfefferbaum A (2000) Extent, pattern, and correlates of remote memory impairment in Alzheimer’s disease and Parkinson’s disease. Neuropsychology 14:265–276
Fastenau PS, Denburg NL, Mauer BA (1998) Parallel short forms for the Boston Naming Test: psychometric properties and norms for older adults. J Clin Exp Neuropsychol 20:828–834
Fernandez HH, Aarsland D, Fenelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG (2008) Scales to assess psychosis in Parkinson’s disease: critique and recommendations. Mov Disord 23:484–500
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Gagnon JF, Bédard MA, Fantini ML, Petit D, Panisset M, Rompré S, Carrier J, Montplaisir J (2002) REM sleep behaviour disorder and REM sleep without atonia in Parkinson’s disease. Neurology 59:585–589
Garcia-Borreguero D, Odin P, Serrano C (2003) Restless legs syndrome and PD: a review of the evidence for a possible association. Neurology 61:49–55
Gilbert B, Belleville S, Bherer L, Chouinard S (2005) Study of verbal working memory in patients with Parkinson’s disease. Neuropsychology 19:106–114
Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2006) Excessive daytime sleepiness in Parkinson’s disease: is it the drugs or the disease? Neurology 67:853–858
Green J, McDonald WM, Vitek JL, Evatt M, Freeman A, Haber M, Bakay RAE, Triche S, Sirockman B, DeLong MR (2002) Cognitive impairments in advanced PD without dementia. Neurology 59:1320–1324
Greene JDW, Hodges JR (1996) Identification of famous faces and famous names in early Alzheimer’s disease: relationship to anterograde episodic and general semantic memory. Brain 119:111–129
Hanagasi HA, Emre M (2002) Management of the neuropsychiatric and cognitive symptoms in Parkinson’s disease. Pract Neurol 2:94–102
Hartje W, Poeck K (2002) Clinical neuropsychology, 5th edn. Thieme, Stuttgart
Henry JD, Crawford JR (2004) Verbal fluency deficits in Parkinson’s disease: a meta-analysis. J Int Neuropsychol Soc 10:608–622
Hickey C, Chisholm T, Passmore MJ, O’Brian JD, Johnston J (2008) Differentiating the dementias. Revisiting synucleinopathies and tauopathies. Curr Alzheimer Res 5:52–60
Higginson CI, Wheelock YL, Carroll KE, Sigvardt KA (2005) Recognition memory in Parkinson’s disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol 27:516–528
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H (1998) The Bayer activities of daily living scale (B-ADL). Dement Geriatr Cogn Disord 9:20–26
Holroyd S, Currie L, Wooten GF (2001) Prospective study of hallucinations and delusions in Parkinson’s disease. J Neurol Neurosurg Psychiatry 70:734–738
Ilmberger J (1999) Revidierter Münchner Verbaler Gedächtnistest (MGT-R). Institut für Medizinische Psychologie der Universität, München
Jefferson AL, Cosentino SA, Ball SK, Bogdanoff B, Leopold N, Kaplan E, Libon DJ (2002) Errors produced on the Mini-Mental State Examination and neuropsychological test performance in Alzheimer’s disease, ischemic vascular dementia, and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 14:311–320
Jellinger KA, Attems J (2008) Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease. Acta Neuropathol 115:427–436
Jesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, Otto M (2009) Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci Ther 15(2):157–182
Josephs KA (2007) Capgras syndrome and its relationship to neurodegenerative disease. Arch Neurol 64:1762–1766
Kalbe E, Calabrese P, Kohn N, Hilker R, Riedel O, Wittchen H-U, Dodel R, Otto J, Ebersbach G, Kessler J (2008) Screening for cognitive deficits in Parkinson’s disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument. Parkinsonism Relat Disord 14:93–101
Kaplan EF, Goodglass H, Weintraub S (1983) The Boston Naming Test, 2nd edn. Lea and Febiger, Philadelphia
Kessels RPC, van Zandvoort MJE, Postma A, Kappelle LJ, de Haan EHF (2000) The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol 7:252–258
Knoke D, Taylor AE, Saint-Cyr JA (1998) The differential effects of cueing on recall in Parkinson’s disease and normal subjects. Brain Cogn 38:261–274
Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S, Ferrer I, Gelpi E, Kövari V, Kretzschmar H, Nagy Z, Parchi P, Seilhean D, Soininen H, Troakes C, Budka H (2008) Mixed brain pathologies in dementia: The BrainNet Europe Consortium Experience. Dement Geriatr Cogn Disord 26:343–350
Kuzis G, Sabe L, Tiberti C, Merello M, Leiguarda R, Starkstein SE (1999) Explicit and implicit learning in patients with Alzheimer disease and Parkinson disease with dementia. Neuropsychiatry Neuropsychol Behav Neurol 12:265–269
Leentjens AF, Lousberg R, Verhey F (2002) Markers for depression in Parkinson’s disease. Acta Psychiatr Neurol Scand 106:196–201
Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 23:2004–2014
Lesher EL, Berryhill JS (1994) Validation of the Geriatric Depression Scale—short form among inpatients. J Clin Psychol 50:256–260
Levy R, Dubois B (2006) Apathy and the functional anatomy of the prefrontal cortex–basal ganglia circuits. Cereb Cortex 16:916–928
Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343–348
Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York
Libon DJ, Bogdanoff B, Leopold N, Hurka R, Bonavita J, Skalina S, Swenson R, Gitlin HL, Ball SK (2001) Neuropsychological profiles associated with subcortical white matter alterations and Parkinson’s disease: implications for the diagnosis of dementia. Arch Clin Neuropsychol 16:19–32
Love S (2005) Neuropathological investigation of dementia: a guide for neurologists. J Neurol Neurosurg Psychiatry 76:8–14
Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson’s disease in the clinical phase: potential markers. Lancet Neurol 8:1158–1171
Mazzucchi A, Sinforiani E, Ludovico L, Turla M, Pacchetti C, Brianti R, Parma M, Nappi G (1993) Reaction time responses in parkinsonian and hemiparkinsonian patients. Mov Disord 8:13–18
McFadden L, Mohr E, Sampson M, Mendis T, Grimes JD (1996) A profile analysis of demented and nondemented Parkinson’s disease patients. Adv Neurol 69:339–341
McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124
Molloy SA, Rowan EN, O’Brian JT, McKeith IG, Wesnes K, Burn DJ (2006) Effect of levodopa on cognitive function in Parkinson’s disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:1323–1328
Mosimann UP, Mather G, Wesnes KA, O’Brian JT, Burn DJ, McKeith IG (2004) Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 63:2091–2096
MRC-CFAS (Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study) (2001) Pathological correlates of late-onset dementia in a multicentre community-based population in England and Wales. Lancet 357:169–175
Müller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K, Poewe W, Litvan I (2001) Progression of dysarthria and dysphagia in post-mortem-confirmed parkinsonian disorders. Arch Neurol 58:259–264
Muslimovic D, Post B, Speelman JD, Schmand B (2005) Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239–1245
Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD (1997) The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56:165–170
Pate DS, Margolin DI (1994) Cognitive slowing in Parkinson’s and Alzheimer’s patients: distinguishing bradyphrenia from dementia. Neurology 44:669–674
Perry RJ, Hodges JR (1996) Spectrum of memory dysfunction in degenerative disease. Curr Opin Neurol 9:281–285
Pessoa L, Ungerleider LG (2004) Top-down mechanisms for working memory and attentional processes. In: Gazzaniga MS (ed) The cognitive neurosciences, 3rd edn. MIT Press, Cambridge
Piatt AL, Fields JA, Paolo AM, Koller WC, Tröster AI (1999) Lexical, semantic and action verbal fluency in Parkinson’s disease with and without dementia. J Clin Exp Neuropsychol 21:435–443
Pillon B, Dubois B, Agid Y (1996) Testing cognition may contribute to the diagnosis of movement disorders. Neurology 46:329–334
Poeck K (1985) Pathological laughter and crying. In: Vinken PJ, Bruyn GW, Klawans HL (eds) Handbook of clinical neurology. Elsevier, Amsterdam, pp 219–225
Rashkin SA, Borod JC, Tweedy J (1990) Neuropsychological aspects of Parkinson’s disease. Neuropsychol Rev 1:185–221
Raven JC (1984) Manual for the coloured progressive matrices, revised. NFER-Nelson, Windsor, UK
Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C, Dodel R, Wittchen H-U (2008) Cognitive impairment in 873 patients with idiopathic Parkinson’s disease. Results from the German Study on Epidemiology of Parkinson’s Disease with Dementia (GEPAD). J Neurol 255:255–264
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brian MD, Yamaguchi T, Grafman J, Drayer BP, Bennet DA, Fischer M, Ogota J, Kokmemn E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, Decarli C, Culebras A, Korxzyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260
Roman GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, Lopez-Pousa S, Arizaga R, Wallin A (2004) Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 226:81–87
Salmon DP, Filoteo JV (2007) Neuropsychology of cortical versus subcortical dementia syndromes. Semin Neurol 27:7–21
Schmidt K-H, Metzler P (1992) Wortschatztest (WST). Hogrefe, Göttingen
Schmidt-Atzert L, Krumm S, Bühner M (2008) Assessment of attention: derivation of a structural model and systematic classification of tests. J Neuropsychol 19:59–82
Sheridan MR, Flowers KA, Hurrell J (1987) Programming and execution of movements in Parkinson’s disease. Brain 100:1247–1271
Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case–control study. Mov Disord 15:669–677
Shulman KI, Gold DP, Cohen CA, Zucchero CA (1993) Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatr Psychiatry 8:487–496
Skoog I (2004) Subcortical vascular dementia. Clin Neuropsychol 18:4–5
Smits CHM, Smit JH, van den Heuvel N, Jonker C (1997) Norms for an abbreviated Raven’s Coloured Progressive Matrices in an older sample. J Clin Psychol 53:687–697
Squire LR (1992) Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99:195–231
Starkstein SE, Sabe L, Petracca G, Chemerinski E, Kuzis G, Merello M, Leiguarda R (1996) Neuropsychological and psychiatric differences between Alzheimer’s disease and Parkinson’s disease with dementia. J Neurol Neurosurg Psychiatry 61:381–387
Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 13:895–899
Taylor AE, Saint-Cyr JA (1995) The neuropsychology of Parkinson’s disease. Brain Cogn 28:281–296
Tröster AI (2008) Neuropsychological characteristics of dementia with Lewy bodies and Parkinson’s disease with dementia: differentiation, early detection, and implications for “Mild Cognitive Impairment” and biomarkers. Neuropsychol Rev 18:103–119
Van den Heuvel DMJ, ten Dam VH, de Craen AJM, Admiraal-Behloul F, Olofsen H, Bollen ELEM, Jolles J, Murray HM, Blauw GJ, Westendorp RGJ, van Buchem MA (2006) Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 77:149–153
Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O’Brian JT, Ballard CG (2000) Quantifying fluctuation in dementia with Lewy bodies, Alzheimer’s disease, and vascular dementia. Neurology 54:1616–1625
Warrington EK, James M (1991) The visual object and space perception battery. Thames Valley Test Company, Bury St. Edmunds
Wechsler D (1997) Wechsler Memory Scale, 3rd edn. The Psychological Corporation, San Antonio, TX
Willemssen R, Müller T, Schwarz M, Hohnsbein J, Falkenstein M (2008) Error processing in patients with Parkinson’s disease: the influence of medication state. J Neural Transm 115:461–468
Yesavage JA (1988) Geriatric Depression Scale. Psychopharmacol Bull 24:709–711
Zakzanis KK, Freedman M (1999) A neuropsychological comparison of demented and non-demented patients with Parkinson’s disease. Appl Neuropsychol 6:129–146
Zimmermann P, Fimm B (2007) Testbatterie zur Aufmerksamkeitsprüfung (TAP), 2.1. Vera Fimm Psychologische Testsysteme, Würselen
Acknowledgments
Supported by grants from the Landesstiftung Baden-Württemberg (P-LS-Prot/42).
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Bothe, M.R., Uttner, I. & Otto, M. Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure. J Neural Transm 117, 353–367 (2010). https://doi.org/10.1007/s00702-010-0370-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-010-0370-2